Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.30 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19361064 | 1.00 | PTGS1 (0.41) | PTGS1AKR1C3CYP2C9MAPTFFAR3 | |
| SCHEMBL14952926 | 0.80 | PTGS1 (0.39) | PTGS1AKR1C3CYP2C9MAPTFFAR3 | |
| SCHEMBL5816935 | 0.80 | PTGS1 (0.39) | PTGS1AKR1C3CYP2C9MAPTFFAR3 | |
| SCHEMBL2381716 | 0.80 | PTGS1 (0.39) | PTGS1AKR1C3CYP2C9MAPTFFAR3 | |
| SCHEMBL14952925 | 0.80 | PTGS1 (0.39) | PTGS1AKR1C3CYP2C9MAPTFFAR3 | |
| SCHEMBL12192880 | 0.78 | PTGS1 (0.60) | PTGS1AKR1C3CYP2C9MAPTFFAR3 | |
| SCHEMBL20773730 | 0.78 | PTGS1 (0.38) | PTGS1AKR1C3CYP2C9MAPTFFAR3 | |
| SCHEMBL623803 | 0.75 | HTT (0.45) | PTGS1AKR1C3CYP2C9MAPTFFAR3 | |
| SCHEMBL819848 | 0.75 | — | — | |
| SCHEMBL5893 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231393-B1 | HIGHLY FLAME RETARDANT PANELS | DU PONT (US) | 2013-01-23 | — | — | EP | claimed |
| US-20260108600-A1 | METHODS AND COMPOSITIONS RELATING TO IMPROVED IONIC LIQUID ADJUVANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-04-23 | — | — | US | disclosed |
| US-8722828-B2 | Process for continuous production of cycloolefin resins, and sheets or films thereof, using ring opening metathesis polymerization | ZEON CORPORATION (JP) | 2014-05-13 | — | — | US | disclosed |
| EP-1655319-B1 | POLYMERIZABLE COMPOSITION AND FORMED BODY THEREOF | ZEON CORP (JP) | 2012-03-28 | — | — | EP | disclosed |
| US-7803870-B2 | Polymerizable composition and molded product thereof | ZEON CORPORATION (JP) | 2010-09-28 | — | — | US | disclosed |
| US-7771834-B2 | Method of manufacturing thermoplastic resin, crosslinked resin, and crosslinked resin composite material | ZEON CORPORATION (JP) | 2010-08-10 | — | — | US | disclosed |
| US-20100124615-A1 | Process for Producing Crosslinkable Resin Formed Product | ZEON CORPORATION (JP) | 2010-05-20 | — | — | US | disclosed |
| US-7666966-B2 | Method of manufacturing thermoplastic resin, crosslinked resin, and crosslinked resin composite material | ZEON CORPORATION (JP) | 2010-02-23 | — | — | US | disclosed |
| US-20100015871-A1 | MOLDED ARTICLE, PROCESS FOR PRODUCING THE SAME, AND CROSSLINKED MOLDED ARTICLE AND COPPER-CLAD LAMINATE EACH OBTAINED THEREFROM | ZEON CORPORATION (JP) | 2010-01-21 | — | — | US | disclosed |
| US-20090305018-A1 | Crosslinkable-Resin Formed Product, Crosslinked-Resin Formed Product, and Crosslinked Resin-Metal Clad Laminate | ZEON CORPORATION (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20080125531-A1 | Polymerizable Composition, Thermoplastic Resin Composition, Crosslinked Resin, And Crosslinked Resin Composite Materials | ZEON COROPRATION (JP) | 2008-05-29 | — | — | US | disclosed |
| EP-1535941-B1 | PROCESSES FOR PRODUCING THERMOPLASTIC RESINS, CROSSLINKED RESINS AND CROSSLINKED RESIN COMPOSITE MATERIALS | ZEON CORP (JP) | 2007-09-12 | — | — | EP | disclosed |
| US-20070191563-A1 | Method of manufacturing thermoplastic resin, crosslinked resin, and crosslinked resin composite material | ZEON CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070037946-A1 | Process for producing cycloolefin resin film and process for producing cycloolefin polymer sheet or film | ZEON CORPORATION (JP) | 2007-02-15 | — | — | US | disclosed |
| US-20060293444-A1 | Polymerizable composition and molded product thereof | ZEON CORPORATION (JP) | 2006-12-28 | — | — | US | disclosed |
| US-20060211834-A1 | Method of manufacturing thermoplastic resin, crosslinked resin, and crosslinked resin composite material | ZEON CORPORATION (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1655319-A1 | POLYMERIZABLE COMPOSITION AND FORMED BODY THEREOF | Zeon Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
| EP-1589055-A1 | PROCESS FOR PRODUCING CYCLOOLEFIN RESIN FILM AND PROCESS FOR PRODUCING CYCLOOLEFIN POLYMER SHEET OR FILM | Zeon Corporation (JP) | 2005-10-26 | — | — | EP | disclosed |
| EP-1589054-A1 | POLYMERIZABLE COMPOSITION, THERMOPLASTIC RESIN COMPOSITION, CROSSLINKED RESIN, AND CROSSLINKED RESIN COMPOSITE MATERIALS | Zeon Corporation (JP) | 2005-10-26 | — | — | EP | disclosed |
| EP-1535941-A1 | PROCESSES FOR PRODUCING THERMOPLASTIC RESINS, CROSSLINKED RESINS AND CROSSLINKED RESIN COMPOSITE MATERIALS | ZEON CORPORATION (JP) | 2005-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108600-A1 | METHODS AND COMPOSITIONS RELATING TO IMPROVED IONIC LIQUID ADJUVANTS | ICOS, ICOSLG, TLR9 | PTGS1 3121/4885AKR1C3 4003/4885CYP2C9 3948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.